spacer
home > ict > spring 2020 > a digital approach to enrolment
PUBLICATIONS
International Clinical Trials

A Digital Approach to Enrolment



ICT: What is the current market need for greater patient recruitment strategies?

Barbara and Nathalie: Recruitment of patients and healthy volunteers for clinical trials is a well-known bottleneck. The success and timelines for attracting and enrolling patients have a direct impact on the time it takes to get a drug or medical device to the market. Delays result in higher operating costs, losses in sales, and many other drawbacks. In recent years, there has been increasing demand for specialised patient recruitment services in Europe. Approaches that apply for US-based clinical trials cannot be copied Ďas isí for clinical trials in Europe.

In Europe, it is challenging to navigate through the complex regulatory landscape. There are few or no rules and only minimal guidelines with respect to patient recruitment strategies. Additionally, substantial cultural differences across countries require country-specific recruitment approaches and a high degree of customisation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the authors

Barbara Díhaene brings to the company over 10 years of experience in innovation management. In 2015, she was one of the founders of the patient management company Akcelis, which was acquired by Pivotal early 2020. Together with Nathalie Niclaus, she developed innovative patient-centric solutions.

As Co-Founder of Akcelis, Nathalie Niclaus designed and implemented practical solutions to overcome some of the hurdles in clinical trials. She combined all her experience and knowledge of clinical trials to develop innovative solutions and strategies for successful clinical trial patient recruitment and retention.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires

Cambridge, UK, 10 May 2022: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed three new hires to its commercial team. Evelyn Stevenson and Ravi Girdhar join as Director of Product Management and Director of Sales (EMEA), respectively, alongside Denise Emsden as Vice-President of People and Organizational Development. Following the closure of a £26 million GBP (c. $36 million USD) funding round in 20211, the appointments support the Companyís next stage of development to expand product research and development, international operations and sales in key global markets.
More info >>

White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement